Clinical Research Directory

Brain Oligometastasis in NSCLC

Sponsor: University Hospital, Bordeaux

Summary

75-80% of NSCLC are diagnosed at the metastatic stage. Among the most frequent sites are brain metastases. The management of patients with exclusive limited brain involvement is not standardized. The question is therefore which therapeutic strategy is optimal in such disease presentation. We will analyze the impact of different therapeutic strategies on patients treated at Bordeaux University Hospital and the Bergonié Institute

Official title: Management of Patients With Brain-onset Oligometastatic Non-small-cell Lung Cancer (NSCLC)

Key Details

Conditions

Interventions

Locations (1)